Skip to content

E4 Pharmaceutical Consulting

E4 Biotechnology and Pharmaceutical Consulting. Providing product development (CMC), regulatory, QA/QC and project management support to companies developing new small-molecule drugs, biologics and medical devices.

Welcome!!

Categories

  • Regulatory (2)
    • Regulatory Strategy (1)
    • Regulatory Submissions (2)

E4 Pharmaceutical Consulting

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS FDA News

RSS Pharma Times

  • KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
    Phase 1 study to assess safety and early efficacy of KMA‑targeting car‑t in multiple myeloma
  • Pepaxti study supports use in wider myeloma population
    Phase 2 bridge data show consistent outcomes in patients with impaired kidney function
  • UCB reports positive outcomes for bimekizumab in psoriatic arthritis
    Trial shows first head‑to‑head superiority in joint endpoints for an approved PsA biologic
  • AstraZeneca wins US approval for first‑in‑class Baxfendy in hypertension
    Baxdrostat delivers clinically meaningful blood pressure reductions in phase 3 BaxHTN trial
  • Cellbxhealth partners with AdventHealth on CTC‑based monitoring in two major cancer studies
    Parsortix platform to support minimally invasive analysis across various cancer trials
  • Microbiotica reports positive results for MB097 in advanced melanoma
    Data suggests microbiome co-therapy may help overcome resistance to anti‑PD‑1 treatment
Proudly powered by WordPress / Theme: Shoreditch by Automattic.